These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Future perspectives and implications. Sleight P. Int J Clin Pract Suppl; 2001 Jan 14; (117):22-3. PubMed ID: 11715355 [Abstract] [Full Text] [Related]
7. The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators. Can J Cardiol; 1996 Feb 14; 12(2):127-37. PubMed ID: 8605634 [Abstract] [Full Text] [Related]
8. Diabetes and the HOPE study: implications for macrovascular and microvascular disease. Gerstein HC. Int J Clin Pract Suppl; 2001 Jan 14; (117):8-12. PubMed ID: 11715357 [Abstract] [Full Text] [Related]
11. Effect of long-term ACE-inhibitor therapy in elderly vascular disease patients. Gianni M, Bosch J, Pogue J, Probstfield J, Dagenais G, Yusuf S, Lonn E. Eur Heart J; 2007 Jun 14; 28(11):1382-8. PubMed ID: 17395677 [Abstract] [Full Text] [Related]
12. Why were the results of the Heart Outcomes Prevention Evaluation (HOPE) trial so astounding? Mancini GB, Stewart DJ. Can J Cardiol; 2001 May 14; 17 Suppl A():15A-7A. PubMed ID: 11381289 [Abstract] [Full Text] [Related]
13. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. Lüders S, Schrader J, Berger J, Unger T, Zidek W, Böhm M, Middeke M, Motz W, Lübcke C, Gansz A, Brokamp L, Schmieder RE, Trenkwalder P, Haller H, Dominiak P, PHARAO Study Group. J Hypertens; 2008 Jul 14; 26(7):1487-96. PubMed ID: 18551027 [Abstract] [Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. Vijan SG. J Indian Med Assoc; 2009 Mar 14; 107(3):178-82. PubMed ID: 19810392 [Abstract] [Full Text] [Related]
19. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA? Boos CJ. Med Sci Monit; 2004 Dec 15; 10(12):SR23-8. PubMed ID: 15567997 [Abstract] [Full Text] [Related]
20. [The HOPE Study. What does it contribute to general practice?]. Mann J, Sleight P. MMW Fortschr Med; 2000 Nov 23; 142(47):28-32. PubMed ID: 11143776 [Abstract] [Full Text] [Related] Page: [Next] [New Search]